SPHERA FUNDS MANAGEMENT LTD.
Position in IKT — Inhibikase Therapeutics, Inc.
CIK 1496201
TEL AVIV, L3
Position in IKT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,318,097
New position
Shares Held
649,309
first reported quarter
Ownership
0.465%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#24
of 105 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026SPHERA FUNDS MANAGEMENT LTD. holds $446,002,188 across 71 Biotechnology names. IKT ranks #63 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MLYS |
Mineralys Therapeutics, Inc.
|
1,469,971 | $39,659,817 | |
| 2 | SNDX |
Syndax Pharmaceuticals Inc
|
1,014,606 | $22,179,287 | |
| 3 | RARE |
Ultragenyx Pharmaceutical Inc.
|
588,494 | $19,649,814 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
328,550 | $18,799,631 | |
| 5 | CYTK |
Cytokinetics Inc
|
219,987 | $18,740,692 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
245,346 | $18,273,370 | |
| 7 | COGT |
Cogent Biosciences, Inc.
|
459,340 | $17,776,458 | |
| 8 | INSM |
INSMED Inc
|
118,800 | $12,666,456 |
All Filings in IKT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,318,097 | 649,309 | Shares | Defined | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||